Cargando…
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the pre...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649938/ https://www.ncbi.nlm.nih.gov/pubmed/23651475 http://dx.doi.org/10.1186/1471-2407-13-228 |
_version_ | 1782269041559207936 |
---|---|
author | Conesa-Zamora, Pablo Ruiz-Cosano, Javier Torres-Moreno, Daniel Español, Ignacio Gutiérrez-Meca, María D Trujillo-Santos, Javier Pérez-Ceballos, Elena González-Conejero, Rocío Corral, Javier Vicente, Vicente Pérez-Guillermo, Miguel |
author_facet | Conesa-Zamora, Pablo Ruiz-Cosano, Javier Torres-Moreno, Daniel Español, Ignacio Gutiérrez-Meca, María D Trujillo-Santos, Javier Pérez-Ceballos, Elena González-Conejero, Rocío Corral, Javier Vicente, Vicente Pérez-Guillermo, Miguel |
author_sort | Conesa-Zamora, Pablo |
collection | PubMed |
description | BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the prevalence of three functional polymorphisms affecting these genes rs1051740 EPHX1, rs1800566 NQO1 and rs662 PON1 in 215 patients with lymphoma and 214 healthy controls. RESULTS: Genotype frequencies for EPHX and NQO1 polymorphisms did not show any correlation with disease. In contrast, the GG genotype in the PON1 polymorphism was found to be strongly associated with the disease (15.3% vs. 4.7%; OR = 3.7 CI (95%): 1.8-7.7; p < 0.001). According to the pathological diagnosis this association was related to follicular (p = 0.004) and diffuse large B-cell (p = 0.016) lymphomas. CONCLUSIONS: Despite the fact that further confirmation is needed, this study shows that the PON1 GG genotype in rs662 polymorphism could be a risk factor for B-cell lymphomas. |
format | Online Article Text |
id | pubmed-3649938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36499382013-05-10 Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study Conesa-Zamora, Pablo Ruiz-Cosano, Javier Torres-Moreno, Daniel Español, Ignacio Gutiérrez-Meca, María D Trujillo-Santos, Javier Pérez-Ceballos, Elena González-Conejero, Rocío Corral, Javier Vicente, Vicente Pérez-Guillermo, Miguel BMC Cancer Research Article BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the prevalence of three functional polymorphisms affecting these genes rs1051740 EPHX1, rs1800566 NQO1 and rs662 PON1 in 215 patients with lymphoma and 214 healthy controls. RESULTS: Genotype frequencies for EPHX and NQO1 polymorphisms did not show any correlation with disease. In contrast, the GG genotype in the PON1 polymorphism was found to be strongly associated with the disease (15.3% vs. 4.7%; OR = 3.7 CI (95%): 1.8-7.7; p < 0.001). According to the pathological diagnosis this association was related to follicular (p = 0.004) and diffuse large B-cell (p = 0.016) lymphomas. CONCLUSIONS: Despite the fact that further confirmation is needed, this study shows that the PON1 GG genotype in rs662 polymorphism could be a risk factor for B-cell lymphomas. BioMed Central 2013-05-07 /pmc/articles/PMC3649938/ /pubmed/23651475 http://dx.doi.org/10.1186/1471-2407-13-228 Text en Copyright © 2013 Conesa-Zamora et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Conesa-Zamora, Pablo Ruiz-Cosano, Javier Torres-Moreno, Daniel Español, Ignacio Gutiérrez-Meca, María D Trujillo-Santos, Javier Pérez-Ceballos, Elena González-Conejero, Rocío Corral, Javier Vicente, Vicente Pérez-Guillermo, Miguel Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title | Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title_full | Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title_fullStr | Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title_full_unstemmed | Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title_short | Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study |
title_sort | polymorphisms in xenobiotic metabolizing genes (ephx1, nqo1 and pon1) in lymphoma susceptibility: a case control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649938/ https://www.ncbi.nlm.nih.gov/pubmed/23651475 http://dx.doi.org/10.1186/1471-2407-13-228 |
work_keys_str_mv | AT conesazamorapablo polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT ruizcosanojavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT torresmorenodaniel polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT espanolignacio polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT gutierrezmecamariad polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT trujillosantosjavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT perezceballoselena polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT gonzalezconejerorocio polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT corraljavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT vicentevicente polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy AT perezguillermomiguel polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy |